- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 278 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 461 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 483 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 362 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 371 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 488 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 278 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 374 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 364 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 369 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 268 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 280 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 383 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 471 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 380 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 277 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more